Naveh Pharma

Naveh Pharma Overview

Naveh Pharma develops and manufactures pharmaceuticals and other healthcare products. Many of the companys supplements include magnesium mixed with other nutrients. Its Magnox Osteo is designed to promote bone health, and Magnox Lady may reduce the symptoms of premenstrual syndrome. Naveh Pharma also develops several proprietary pharmaceutical products for treating symptoms related to ear, nose, and throat conditions. The company is a licensed distributor of prescription pharmaceuticals, over-the-counter medicines, and natural health products. Naveh Pharma represents several international pharmaceutical companies, including Laboratories Fumouze in France, Merck OTC in Germany, Nepentes in Poland, Demo S.A. in Greece, and ESI in Italy.

Latest News

Sep 10, 2022 · www.themarker.com

growth-positive

עם עסקות ב-100 מיליון שקל, דיפלומט מנסה להתרחק מהתלות שלה ביבוא מוצרים

דיפלומט continues to diversify its activities by acquiring two companies in the pharmaceutical and nutritional products market in Israel, Europe, and Australia. The company aims to reduce its dependence on the import and distribution of Procter & Gamble brands. The acquired companies are נוה פארמה and ביגדם, which develop and market magnesium supplements and private label brands for pharmaceutical companies.

AcquisitionExpand

Apr 13, 2022 · finance.walla.co.il

growth-positive

חברת "נוה פארמה" ממציאה לנו פטנטים - וואלה! כסף

נוה פארמה, an Israeli pharmaceutical company, has launched new products including a natural dietary supplement based on saffron. The company, led by Nitzan Primor, specializes in the import, development, production, and marketing of medical devices and health products in Israel. The companys new products are designed to alleviate the suffering of people, improving their quality of life. The companys new products include a dietary supplement for mental health, a supplement for joint pain, and a supplement for fibromyalgia.

CustomersExpand

Mar 1, 2022 · www.globenewswire.com

growth-positive

SAFFRON TECH ENTERS STRATEGIC PARTNERSHIP WITH NAVEH PHARMA TO CREATE PREMIUM SAFFRON-BASED COSMETICS AND SUPPLEMENTS

Sativus Tech Corps subsidiary, Saffron Tech, has signed a non-binding LOI with Naveh Pharma to create a joint venture. The joint venture aims to accelerate growth for both companies by supplying Naveh Pharmas saffron-based supplements. Saffron Tech will invest $1.5 million and hold 70% of the equity in the joint venture. Naveh Pharma will commit to purchasing at least 100 kg of saffron extract from Saffron Tech at over $2,000 per kg. The joint venture plans to develop and distribute a line of saffron-based food supplements globally in 2022 and launch a line of saffron-based cosmetics in the second half of 2022. The completion of the deal is subject to signing a definitive agreement by the end of March 2022.

PartnersInvestment

Funding

Team Members

3

Employees: 11-50

Web & Social Links

Locations

Yad Harutsim St 11, Netanya, Israel

Photos & Videos

2 item(s)

Naveh Pharma Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info